elderly man with head breaking apart

Feasibility Study Finds Informative Digital Biomarkers of Dementia

Combining wearable devices, handheld devices and digital apps lets researchers tell the difference between people with early dementia and those without it.

Largest Study to Date of COVID-19 Susceptibility Launched

Researchers will launch the study involving 1,000 subjects—consisting of COVID-19 patients and their partners and first-degree relatives as controls—to compare a variety of genomic and other biological variables between those patients who show no or mild symptoms and those who show severe illness.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine

Illumina’s BlueBee Acquisition Strengthens its Cloud Portfolio

Illumina said it expects BlueBee’s cloud capability to lower the cost of storing, sharing and managing the genomic data that streams from Illumina’s installed base of more than 15,000 sequencing systems.
Security padlock in circuit board

A New Approach to Sharing Patient Data and Maintaining Privacy

In the new approach, patients are provided an additional informed consent document regarding sharing their information that research participants can choose to sign. This additional, or special consent, is additive to the standard informed consent papers required for participating in a research project.
Gemome Sequence Map

Big Data and Clinical Genomics

Progress Is Being Made Toward Using Big Data for Genomics-Guided Precision Medicine Precision medicine springs from a paradox. On the one hand, researchers in the...
GenomOncology's proprietary match algorithm and extensive Knowledge Management System (KMS) application programming interface (API) suite will be used by Indiana University (IU) School of Medicine to provide real-time clinical trial recommendations to clinical researchers treating IU patients

MD Anderson, Philips Collaborate to Broaden Access to Clinical Oncology Support Tool

The PODS system was developed at MD Anderson to aid oncologist in therapeutic decision making for their patients at the point of care based on existing evidence of effective treatment regimens. It provides clinicians with a list of approved therapies and matches the patient to available clinical trials based on the genetic profile of their tumor.

LunaDNA Enables EHR Data Collection through Medfusion Collaboration

LunaPBC, the public-benefit corporation which oversees the LunaDNA community-owned genomic and health data platform, said today that members will now be able to access...

TruGenomix, BlueBee Launch Behavioral Health Partnership Sparked by COVID-19

The companies said they will train, model, and expand insights continuously using machine learning and artificial intelligence, with the goal of enabling early identification of people at high risk for PTSD and other behavioral health conditions based on their biomarkers.
Biotechnology, conceptual illustration

Mayo Clinic, Google Partner on AI-Based Diagnostics, Cloud Computing

Mayo Clinic and Google said they will jointly develop artificial intelligence (AI)-based diagnostics and carry out medical research using Google Cloud to store and...
Scroll Up